Nilüfer Broeders

Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation

Sylvie Euvrard, Emmanuel Morélon, Lionel Rostaing et al. · New England Journal of Medicine · 2012 · 585 citations · Full text

Medicine, Dermatology, Oncology +17

The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

Éric Rondeau, Marie Scully, Gema Ariceta et al. · Kidney International · 2020 · 219 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Cold Ischemia is a Major Determinant of Acute Rejection and Renal Graft Survival in the Modern Era of Immunosuppression

Dimitri Mikhalski, Karl Martin Wissing, Lidia Ghisdal et al. · Transplantation · 2008 · 171 citations

Medicine, Immunology, Nephrology +17

Fibrate‐induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?

Nilüfer Broeders, Christiane Knoop, Martine Antoine et al. · Nephrology Dialysis Transplantation · 2000 · 166 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results

Jacques Dantal, Emmanuel Morélon, Lionel Rostaing et al. · Journal of Clinical Oncology · 2018 · 129 citations

Medicine, Oncology, Pharmacology +15